PDB14 COST-EFFECTIVENESS OF MONO- AND COMBINATION THERAPY WITH PIOGLITAZONE COMPARED TO GLICLAZIDE IN PATIENTS WITH TYPE-2-DIABETES MELLITUS FROM A GERMAN STATUTORY HEALTH CARE PERSPECTIVE

Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65957-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)65957-8/fulltext
Title : PDB14 COST-EFFECTIVENESS OF MONO- AND COMBINATION THERAPY WITH PIOGLITAZONE COMPARED TO GLICLAZIDE IN PATIENTS WITH TYPE-2-DIABETES MELLITUS FROM A GERMAN STATUTORY HEALTH CARE PERSPECTIVE
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65957-8&doi=10.1016/S1098-3015(10)65957-8
First page :
Section Title :
Open access? : No
Section Order : 325
Categories :
Tags :
Regions :
ViH Article Tags :